Clinical Trial: Pharmacokinetic (PK) Evaluation of Intravenous (IV) Nalmefene 0.5 mg (0.94% MgCl2) and Nalmefene Hydrochloride Injection 0.5 mg and Intramuscular (IM) Nalmefene 0.5 mg (0.94% MgCl2)

U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07543276) titled 'Pharmacokinetic (PK) Evaluation of Intravenous (IV) Nalmefene 0.5 mg (0.94% MgCl2) and Nalmefene Hydrochloride Injection 0.5 mg and Intramuscular (IM) Nalmefene 0.5 mg (0.94% MgCl2)' on April 15.

Brief Summary: This study is designed to characterize the PK of nalmefene following IV bolus and IM injections using nalmefene 0.5 mg (0.94% MgCl2) and IV bolus of 0.5 mg nalmefene hydrochloride injection in healthy subjects.

Study Start Date: Feb. 06

Study Type: INTERVENTIONAL

Condition: Opioid Overdose

Intervention: DRUG: Nalmefene + 0.94% MgCl2

Nalmefene 0.5 mg + 0.94% MgCl2 for IV (bolus) administration

DRUG: Nalmefene + 0.94% ...